FIELD: medicine, pharmaceutics.
SUBSTANCE: there are offered: a pharmaceutical composition for preventing or treating atherosclerosis, metabolic syndrome, diabetes, obesity or their symptoms, or the combinations thereof, containing a pharmaceutically effective amount of D-tagatose or a salt, sugar alcohol, hydrate, solvate, ester or amide thereof, and a pharmaceutically effective amount of a second pharmaceutically active agent containing stilbene or a stilbenoid component or any salt, alcohol, hydrate, ester, amide, polymorph, isomer thereof, or a combination thereof, a related method of treating or preventing these diseases, the use of said composition for preparing a medicine or vaccine for the same application and a food stuff containing a pharmaceutically effective amount of D-tagatose or a salt, sugar alcohol, hydrate, solvate, ester or amide thereof, and a pharmaceutically effective amount of a second pharmaceutically active agent containing stilbene or a stilbenoid component or a salt, alcohol, hydrate, ester, amide, polymorph, isomer thereof, or a combination thereof.
EFFECT: declared combination reduces blood plasma triglyceride, including in additional carbon diet.
30 cl, 3 ex
Title |
Year |
Author |
Number |
COMBINATIONS AND COMPOSITIONS CONTAINING FATTY ACIDS AND AMINO ACIDS, THEIR APPLICATION FOR PREVENTION AND DELAY OF PROGRESSING OR TREATMENT OF DIABETES AND DIABETES ASSOCIATED DISEASES AND CONDITIONS, METHOD OF WEIGHT REDUCTION IN MAMMAL, KIT |
2004 |
- Troup Dzhon P.
- Ber Mikhaehl'
|
RU2356247C2 |
METHODS AND COMPOSITIONS FOR TREATING OBESITY, PREVENTING MASS INCREASE, PROMOTING MASS REDUCTION, PROMOTING WEIGHT LOSS OR TREATING OR PREVENTING DIABETES FROM DEVELOPING |
2015 |
- Gojon-Zorrilla, Gabriel
- Gojon-Romanillos, Gabriel
|
RU2745440C2 |
USE OF A COMPOSITION CONSISTING OF THE AMINO ACIDS GLYCINE, ARGININE, CYSTEINE AND RESVERATROL TO REDUCE THE SEVERITY OF DIABETES AND HIGH CONTENT OF FAT, CHOLESTEROL, URIC ACID, BLOOD GLUCOSE AND ACCELERATED AGING IN ANIMALS AND HUMANS |
2017 |
- Astudillo De La Vega, Horacio
|
RU2749950C2 |
DOCOSAHEXAENOIC ACID DERIVATIVES AND THEIR APPLICATION AS DRUGS |
2006 |
- Brin Morten
- Kholmejd Ehnn Kristen
- Kopetski Jan
|
RU2441061C2 |
FOOD PRODUCT FOR DIABETICS |
2005 |
- Shul'Man Avidor
- Pelled Dori
- Kouehn Tsafra
|
RU2380983C2 |
COMPOSITION CONTAINING AKKERMANSIA MUCINIPHILA AND GREEN TEA EXTRACT |
2021 |
- Kani Patris
- Broshe Amandin
|
RU2829638C1 |
FGF21 Fc FUNCTION PROTEIN, GLP-1 Fc FUNCTION PROTEIN AND COMBINED THERAPEUTIC AGENT INCLUDING THEM AND THEIR USE |
2020 |
- Dun, Chzhao
- Chzhou, Chi
- Chzhan, Tsziyu
- Li, Yuanli
- Li, Tsyan
|
RU2804335C2 |
METHOD OF IMPROVEMENT OF LIVER FUNCTION |
2013 |
- Uolder Ken
- Krippner Gaj
- Nikolson Dzhoff
|
RU2653478C2 |
ACYLATED GLUCAGON ANALOGUE, USE THEREOF AND METHODS OF PRODUCING |
2016 |
- Riber, Ditte
- Tolborg, Yakob Lind
- Khamprekht, Diter Volfgang
- Tomas, Leo
|
RU2735762C2 |
COMPOSITION USED TO COMBAT METABOLIC DISEASES AND USE OF COMPOSITION |
2020 |
- Ng, Shyh Chang
- Ma, Shi Lin
|
RU2827553C1 |